Rovia Clinical Research, a multi-specialty, clinical research site network, on Thursday announced the launch of a new, dedicated clinical research site at the Hattiesburg Clinic (HBC) in Hattiesburg, Mississippi, in partnership with principal investigator Dr. Rambod Rouhbakhsh.
HBC, a privately-owned, multi-specialty health system in Mississippi, accommodates more than 450 physicians and providers and serves patients across 17 counties with around 2,000 staff members.
This collaboration extends Rovia's footprint into Mississippi and aims to improve its capabilities in key therapeutic areas while reinforcing a shared, patient-centric mission to advance clinical research.
"The Hattiesburg Clinic and Dr. Rouhbakhsh are highly respected in the region and nation, and we are thrilled to partner with them to launch this new site in an underserved, major geographic region," commented Rovia CEO Patricio Casillas.
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Kiora Pharmaceuticals joins Global Genes' RARE-X Vision Consortium
Pilatus Biosciences to present new preclinical data on PLT012 at SITC 2025
Rovia Clinical Research opens new clinical research site in Hattiesburg, Mississippi
ChemDiv extends CMC services collaboration supporting clinical development of ratutrelvir
NeuroKaire and Compass Pathways partner to advance AI-driven research in psychedelic psychiatry
BioArctic reports third-quarter royalties from Leqembi sales
GenSight Biologics secures FDA authorisation for expanded access to GS010/LUMEVOQ in the US
AnHorn Medicines reports positive results from US Phase I trial of AH-001
Curasight advances Phase 2 prostate cancer trial with Curium partnership
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Hemogenyx Pharmaceuticals advances HG-CT-1 trial and opens paediatric recruitment
Rx to Go receives ACHC re-accreditation for pharmacy services